A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection

NCT03053505 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection

Interventions

BIOLOGICAL: faecal human microbiota transplant (FMT)
DRUG: Vancomycin or Fidaxomicin

Sponsor

Sejtterapia Kozpont Kft.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]